Paige Baldwin

A nano-liposome formulation of the PARP inhibitor Talazoparib enhances treatment efficacy and modulates immune cell populations in mammary tumors of BRCA-deficient mice

Di Zhang, Paige Baldwin, Ana S. Leal et al. · Theranostics · 2019 · 66 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Nanoformulation of Olaparib Amplifies PARP Inhibition and Sensitizes <i>PTEN/TP53-</i> Deficient Prostate Cancer to Radiation

Anne L. van de Ven, Shifalika Tangutoori, Paige Baldwin et al. · Molecular Cancer Therapeutics · 2017 · 56 citations

Medicine, Oncology, Pharmacology +17

Combined modality therapy with radiotherapy, chemotherapy, and immunotherapy in limited small-cell carcinoma of the lung: a Phase III cancer and Leukemia Group B Study.

L. Herbert Maurer, Thomas F. Pajak, Walter L. Eaton et al. · Journal of Clinical Oncology · 1985 · 49 citations

Medicine, Oncology, Radiation Oncology +12

Sustained Release Talazoparib Implants for Localized Treatment of <i>BRCA1</i>-deficient Breast Cancer

Jodi Belz, Rajiv Kumar, Paige Baldwin et al. · Theranostics · 2017 · 30 citations · Full text

Medicine, Oncology, Pharmacology +15

A phase I–II study of high-dose melphalan, mitoxantrone and carboplatin with peripheral blood stem cell support in patients with advanced ovarian or breast carcinoma

CH Weaver, FA Greco, J. D. Hainsworth et al. · Bone Marrow Transplantation · 1997 · 29 citations

Medicine, Oncology, Pharmacology +17